The Collaborative Research Network (CRN) is a first-of-its-kind global community of multidisciplinary and multi-institutional teams working together to spark new discoveries in Parkinson’s disease (PD) research. The CRN is a program of the Aligning Science Across Parkinson’s (ASAP) initiative, managed by the Coalition for Aligning Science and implemented by the Michael J. Fox Foundation.
The ASAP CRN supports 35 research teams across 14 countries, focusing on critical areas such as functional genomics in Parkinson’s disease, neuro-immune interactions, circuitry and brain-body interactions. With collaboration at its core, the CRN brings together hundreds of investigators to share expertise, findings, and tools in an effort to tackle challenges in the PD space. As a community, we promote standards for openness, real-world utility, and collective impact across scientific research.
The Aligning Science Across Parkinson’s (ASAP) initiative launched the CRN in 2020 to catalyze breakthroughs in PD research. ASAP fosters connections across the scientific community by supporting a variety of programs designed to enhance collaboration and promote sharing of scientific findings, tools, and technologies.
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
Members of the CRN work diligently to advance our understanding of Parkinson’s disease. Learn more about recent CRN discoveries and achievements.
San Diego Supercomputer Zeros In on Parkinson’s Motor ‘Off Switch’
Read how Team Wichmann used the Expanse supercomputer at the San Diego Supercomputer Center to conduct a brain simulation study that suggests that a single type of cortical cell may be the primary cause of the beta-frequency brain waves that afflict people with Parkinson's disease.
Cracking the Code of Parkinson’s: How Supercomputers Are Pointing to New Treatments
Read about how Team Wichmann used ACCESS allocations on the Expanse system at the San Diego Supercomputer Center to model how specific brain cells malfunction in Parkinson’s disease, which could help pave the way for more targeted treatments.
The Components of GP2’s 11th Data Release
GP2's 11th data release brings the total samples to more than 100,000 from individuals worldwide, making it one of the most comprehensive and globally representative PD datasets to date.